IEEE Reviews in Biomedical Engineering,
Journal Year:
2024,
Volume and Issue:
18, P. 211 - 230
Published: Dec. 9, 2024
Cardiac
organoids
represent
an
important
bioengineering
opportunity
in
the
development
of
models
to
study
human
heart
pathophysiology.
By
incorporating
multiple
cardiac
cell
types
three-dimensional
culture
and
developmentally-guided
biochemical
signaling,
recapitulate
numerous
features
tissue.
However,
tissue
also
experiences
a
variety
mechanical
forces
as
develops
over
course
each
contraction
cycle.
It
is
now
clear
that
these
impact
cellular
specification,
phenotype,
function,
should
be
incorporated
into
engineering
order
generate
better
models.
In
this
review,
we
discuss
strategies
for
report
effects
organoid
design
on
function
cells.
We
then
environment
heart,
including
arising
from
elasticity,
contraction,
blood
flow,
stretch,
efforts
mimic
biophysical
cues
organoids.
Finally,
review
emerging
areas
research,
development,
formation
multi-organ
models,
simulation
spaceflight
consider
how
investigations
might
benefit
inclusion
cues.
Cell Proliferation,
Journal Year:
2024,
Volume and Issue:
57(8)
Published: March 7, 2024
Abstract
Human
induced
pluripotent
stem
cell
(hiPSC)‐derived
cardiac
organoids
(COs)
have
shown
great
potential
in
modelling
human
heart
development
and
cardiovascular
diseases,
a
leading
cause
of
global
death.
However,
several
limitations
such
as
low
reproducibility,
limited
vascularization
difficulty
formation
chamber
were
yet
to
be
overcome.
We
established
new
method
for
robust
generation
COs,
via
combination
methodologies
hiPSC‐derived
vascular
spheres
directly
differentiated
cardiomyocytes
from
hiPSCs,
investigated
the
application
COs
injury
drug
evaluation.
The
we
built
displayed
vascularized
chamber‐like
structure,
hence
named
vaschamcardioids
(vcCOs).
These
vcCOs
exhibited
approximately
90%
spontaneous
beating
ratio.
Single‐cell
transcriptomics
identified
total
six
types
vcCOs,
including
cardiomyocytes,
precursor
cells,
endothelial
fibroblasts,
etc.
successfully
recaptured
processes
fibrosis
vivo
on
showed
that
FDA‐approved
medication
captopril
significantly
attenuated
injury‐induced
functional
disorders.
In
addition,
an
obvious
toxicity
reaction
doxorubicin
dose‐dependent
manner.
developed
three‐step
complex
our
data
suggested
might
become
useful
model
understanding
pathophysiological
mechanisms
developing
intervention
strategies
screening
drugs.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(7), P. 3901 - 3901
Published: March 31, 2024
Cardiovascular
diseases
(CVDs)
are
the
leading
cause
of
death
and
include
several
vascular
cardiac
disorders,
such
as
atherosclerosis,
coronary
artery
disease,
cardiomyopathies,
heart
failure.
Multiple
treatment
strategies
exist
for
CVDs,
but
there
is
a
need
regenerative
damaged
heart.
Stem
cells
broad
variety
with
great
differentiation
potential
that
have
immunomodulatory
properties.
studies
evaluated
efficacy
stem
in
mesenchymal
induced
pluripotent
cell-derived
cardiomyocytes.
These
demonstrated
can
improve
left
ventricle
ejection
fraction,
reduce
fibrosis,
decrease
infarct
size.
Other
investigated
methods
to
survival,
engraftment,
functionality
CVDs.
The
aim
present
review
summarize
current
evidence
on
role
how
their
efficacy.
Materials Today Bio,
Journal Year:
2025,
Volume and Issue:
31, P. 101505 - 101505
Published: Jan. 22, 2025
Cardiac
organoids
offer
sophisticated
3D
structures
that
emulate
key
aspects
of
human
heart
development
and
function.
This
review
traces
the
evolution
cardiac
organoid
technology,
from
early
stem
cell
differentiation
protocols
to
advanced
bioengineering
approaches.
We
discuss
methodologies
for
creating
organoids,
including
self-organization
techniques,
biomaterial-based
scaffolds,
bioprinting,
organ-on-chip
platforms,
which
have
significantly
enhanced
structural
complexity
physiological
relevance
in
vitro
models.
examine
their
applications
fundamental
research
medical
innovations,
highlighting
potential
transform
our
understanding
biology
pathology.
The
integration
multiple
types,
vascularization
strategies,
maturation
has
led
more
faithful
representations
adult
heart.
However,
challenges
remain
achieving
full
functional
maturity
scalability.
critically
assess
current
limitations
outline
future
directions
advancing
technology.
By
providing
a
comprehensive
analysis
field,
this
aims
catalyze
further
innovation
tissue
engineering
facilitate
its
translation
clinical
applications.
Cell Regeneration,
Journal Year:
2025,
Volume and Issue:
14(1)
Published: March 23, 2025
Abstract
The
formation
of
a
blood
vessel
network
is
crucial
for
organ
development
and
regeneration.
Over
the
past
three
decades,
central
molecular
mechanisms
governing
growth
have
been
extensively
studied.
Recent
evidence
indicates
that
vascular
endothelial
cells—the
specialized
cells
lining
inner
surface
vessels—exhibit
significant
heterogeneity
to
meet
specific
needs
different
organs.
This
review
focuses
on
current
understanding
cell
heterogeneity,
which
includes
both
intra-organ
inter-organ
heterogeneity.
Intra-organ
encompasses
arterio-venous
tip-stalk
specialization,
while
refers
organ-specific
transcriptomic
profiles
functions.
Advances
in
single-cell
RNA
sequencing
(scRNA-seq)
enabled
identification
new
subpopulations
comparison
gene
expression
patterns
across
subsets
cells.
Integrating
scRNA-seq
with
other
high-throughput
technologies
promises
deepen
our
at
epigenetic
level
spatially
resolved
context.
To
further
explore
human
organoids
offer
powerful
tools
studying
function
three-dimensional
culture
systems
investigating
endothelial-tissue
interactions
using
Developing
presents
unique
opportunities
unravel
its
implications
disease.
Emerging
technologies,
such
as
organoids,
are
poised
transform
pave
way
innovative
therapeutic
strategies
address
diseases.
Graphical
Stem Cell Research & Therapy,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Oct. 12, 2024
A
healthy
heart
comprises
various
cell
types,
including
cardiomyocytes,
endothelial
cells,
fibroblasts,
immune
and
among
others,
which
work
together
to
maintain
optimal
cardiac
function.
These
cells
engage
in
complex
communication
networks,
known
as
cell-cell
interactions
(CCIs),
are
essential
for
homeostasis,
structure,
efficient
However,
the
context
of
diseases,
undergoes
damage,
leading
alterations
cellular
composition.
Such
pathological
conditions
trigger
significant
changes
CCIs,
causing
rearrangement
transition
between
types.
Studying
these
can
provide
valuable
insights
into
biology
disease
mechanisms,
enabling
development
new
therapeutic
strategies.
While
organoids
advanced
3D
co-culture
technologies
has
revolutionized
vitro
studies
recent
advancements
single-cell
spatial
multi-omics
researchers
with
powerful
convenient
tools
investigate
CCIs
at
unprecedented
resolution.
This
article
provides
a
concise
overview
observed
both
normal
injured
heart,
an
emphasis
on
cutting-edge
methods
used
study
interactions.
It
highlights
such
systems,
omics
technologies,
that
have
enhanced
understanding
CCIs.
Additionally,
it
summarizes
practical
applications
CCI
research
advancing
cardiovascular
therapies,
offering
potential
solutions
treating
by
targeting
intercellular
communication.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 10, 2025
SUMMARY
Coronary
vascularization
and
sympathetic
innervation
of
the
myocardium
is
a
concomitant
event
during
embryonic
heart
development
both
systems
are
crucial
to
ensure
normal
adult
function.
Here
we
describe
self-organized
hiPSC-derived
organoid
that
recreates
coronary
vascular
plexus
neuronal
network
ventricle
myocardium,
with
physiologically
relevant
in-vivo-like
structural
organization
Through
modulation
PDGF-β
VEGF
signalling
pathways,
attained
incorporates
1)
an
external
epicardial
layer
(mesothelium)
DACH1,
NR2F2
WT1
positive
cells,
2)
sub-epicardial
space
from
where
functional
primary
CD31
+
/DACH1
cells
emerge,
3)
compact
myocardial
region
adjacent
epicardium,
enriched
in
proliferative
cardiomyocytes
ECM
deposition,
4)
controls
contraction.
Therefore,
human
described
herein,
unique
model
study
new
regenerative
medicine-based
approaches
restore
promote
re-vascularization
after
ischemic
events
perform
developmental
cardiotoxicity
studies.
Biomimetics,
Journal Year:
2025,
Volume and Issue:
10(4), P. 204 - 204
Published: March 26, 2025
Cardiovascular
disease
remains
the
leading
cause
of
death
worldwide,
yet
despite
massive
investment
in
drug
discovery,
progress
cardiovascular
drugs
from
lab
to
clinic
slow.
It
is
a
complex,
costly
pathway
discovery
and
failure
becomes
more
expensive
as
progresses
along
this
pathway.
The
focus
has
begun
shift
optimisation
vitro
culture
methodologies,
not
only
because
these
must
be
undertaken
are
earlier
on
pathway,
but
also
principles
3Rs
have
become
embedded
national
international
legislation
regulation.
Numerous
studies
shown
myocyte
cell
behaviour
much
physiologically
relevant
3D
compared
2D
culture,
highlighting
advantages
using
3D-based
models,
whether
microfluidic
or
otherwise,
for
preclinical
screening.
This
review
aims
provide
an
overview
challenges
limitations
traditional
routes,
successes
field
models
discovery.
focuses
particular
role
biomimicry
can
play,
around
implementation
within
commercial
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 28, 2025
The
intimate
correlation
between
cardiovascular
diseases
and
other
organ
pathologies,
such
as
metabolic
kidney
diseases,
underscores
the
intricate
interactions
among
these
organs.
Understanding
inter-organ
communications
is
crucial
for
developing
more
precise
drugs
effective
treatments
systemic
diseases.
While
animal
models
have
traditionally
been
pivotal
in
studying
interactions,
human-induced
pluripotent
stem
cells
(hiPSCs)
offer
distinct
advantages
when
constructing
vitro
models.
Beyond
conventional
two-dimensional
co-culture
model,
hiPSC-derived
humanoid
organoids
emerged
a
substantial
advancement,
capable
of
replicating
essential
structural
functional
attributes
internal
organs
vitro.
This
breakthrough
has
spurred
development
multilineage
organoids,
assembloids,
organoids-on-a-chip
technologies,
which
allow
enhanced
physiological
relevance.
These
technologies
shown
great
potential
mimicking
coordinated
organogenesis,
exploring
disease
pathogenesis,
facilitating
drug
discovery.
As
central
system,
heart
serves
focal
point
an
extensively
studied
network
interactions.
review
focuses
on
advancements
challenges
organs,
presenting
comprehensive
exploration
this
cutting-edge
approach
research.